Moderate-temperature DNA cleavage activity of TtAgo activated by dCTP/TthSSB for one-step isothermal microRNAs detection Authors: Jie Fang, Changjing Yuan, Lanlang Peng, Sen Chen, Qinli Pu, Marc Lamy de la Chapelle, Yang Luo, Weiling Fu, Weixian Chen Published: 2026 ABSTRACT Thermus thermophilus Argonaute (TtAgo) is a DNA-guided endonuclease promising for gene editing and molecular diagnostics. However, its high-temperature dependence (65–85 °C) restricts its utility in moderate-temperature scenarios. Here we show that combining deoxycytidine triphosphate (dCTP) with the single-stranded DNA-binding protein from T. thermophilus (TthSSB) enables robust TtAgo activity within 37–60 °C. Mechanistic studies reveal that dCTP increases TtAgo’s conformational flexibility, while TthSSB promotes substrate recruitment, synergistically driving efficient DNA cleavage. Leveraging this mechanism, we develop ERCB-TtAgo (exponential amplification reaction by dCTP/TthSSB-activated TtAgo), a one-step isothermal diagnostic platform for microRNA detection. It achieves femtomolar sensitivity within 40 min and accurately distinguishes hepatocellular carcinoma patients from controls in a 151-sample clinical cohort, matching RT‑qPCR performance. Our work not only surmounts a key limitation of TtAgo but also offers an approach for modulating nuclease activity, paving the way for intelligent biosensing platforms with broad applicability. Introduction In molecular biology, the continuous advancement of gene editing and detection technologies provides critical momentum for life science research and medical diagnostics. Prokaryotic Argonaute proteins (pAgos), a class of programmable nucleases, can utilize short DNA or RNA guides, typically 15–24 nt in length, to mediate the cleavage of complementary nucleic acid targets1,2. Unlike Cas nucleases, pAgos do not require specific sequence motifs (such as PAM3,4) for cleaving target nucleic acids, thus offering greater flexibility in target selection. Furthermore, most pAgos use short single-stranded DNA (ssDNA) as guide molecules (gDNA)5–8, which are inherently more stable than the long RNA guides used by Cas systems, significantly simplifying the design and synthesis of guide nucleic acids. Among them, TtAgo, derived from the thermophilic bacterium T. thermophilus, is one of the most extensively studied members of the pAgos family. This protein has been demonstrated to exhibit efficient DNA-guided DNA cleavage activity at high temperatures of 65–85 °C9–11. Utilizing its high specificity and programmable cleavage capability, researchers have developed various TtAgo-based biosensing technologies for applications such as gene mutation detection9 and antibiotic-resistant bacteria analysis12. However, TtAgo’s functionality strictly depends on high-temperature conditions, which severely limit its practical application under conventional moderate temperatures13,14. For instance, when constructing one-step isothermal amplification detection platforms, TtAgo cannot be directly integrated because most isothermal amplification techniques, such as recombinase polymerase amplification (RPA)15 and exponential amplification reaction (EXPAR)16, operate below 65 °C. Therefore, achieving efficient catalytic activity of TtAgo at moderate temperatures has become a key challenge for expanding its biosensing applications. Similar to most pAgos, TtAgo exhibits a typical six-domain architecture in its crystal structure, comprising the N-terminal domain, inter-domain linker L1, PAZ domain, linker L2, MID domain, and the C-terminal PIWI domain17–19. These domains function coordinately: the PAZ and MID domains form a binding pocket that recognizes and binds the 3’-hydroxyl and 5’-phosphate ends of the guide strand, respectively, thereby stabilizing the guide DNA and facilitating its pairing with the complementary target strand. In the presence of divalent metal ions such as Mg2+, the PIWI domain, which contains the conserved catalytic DEDH residues, exhibits RNase H-like cleavage activity, mediating specific cleavage of the target strand between nucleotides opposite the 10th and 11th positions of the guide strand. To gain deeper insights into the structure-function relationship of pAgos, Hong et al. systematically investigated the conformational dynamics and cleavage activities of various thermophilic pAgos at different temperatures20. The team discovered that at their native physiological temperatures (e.g., 75 °C for TtAgo and 95 °C for PfAgo, another thermophilic Argonaute nuclease from Pyrococcus furiosus), these proteins adopt a loosely-packed structure with a partially-melted surface, which is considered crucial for their efficient DNA cleavage activity. Interestingly, partial destabilization of TtAgo’s structure with urea was shown to enhance its cleavage efficiency within the 70–80 °C range, suggesting that controlled structural perturbation could be a strategy to modulate enzymatic activity at moderate temperatures. In an effort to broaden TtAgo’s practical application temperature window, Luo et al. introduced 2’-fluorine (2’F)-modified nucleotides at the ends of the guide DNA21. By enhancing the stability of guide-target hybridization, they successfully lowered TtAgo’s minimum effective cleavage temperature from 65 °C to 60 °C. Beyond their role in nucleic acid cleavage, pAgos are also involved in native physiological environments, where they participate in prokaryotic immune defense mechanisms such as resisting invasion by foreign genetic elements and phage infection22,23. In addition, growing evidence suggests that pAgos may function in fundamental cellular processes including DNA replication, repair, and gene expression regulation11,24–29. Notably, these complex functions often require collaboration with auxiliary molecules such as RepA (in replication initiation) and RecA (in DNA homologous recombination). This implies that thermophilic TtAgo may also undergo functional modulation in the presence of specific molecules, opening research avenues for achieving efficient catalysis at moderate temperatures. In this study, we discover that the synergistic action of dCTP and TthSSB significantly enhances TtAgo’s cleavage activity within 37–60 °C while strongly inhibiting its activity above 65 °C. To our knowledge, this dual-temperature regulation by the dCTP/TthSSB synergy has not been previously reported. Michaelis-Menten kinetic analysis and fluorescence polarization experiments confirm that TtAgo, when assisted by the dCTP/TthSSB combination, exhibits higher substrate affinity and cleavage efficiency at moderate temperatures. Far-UV circular dichroism (CD) spectroscopy further suggests that dCTP/TthSSB might confer a more flexible conformation to TtAgo under moderate-temperature conditions. Based on these findings, we develop an ERCB-TtAgo (exponential amplification reaction by dCTP/TthSSB-activated TtAgo) detection method by taking advantage of the high activity of dCTP/TthSSB-assisted TtAgo at moderate temperatures, enabling one-step, closed-tube, isothermal and highly sensitive detection of miRNAs. Consequently, the ERCB-TtAgo system offers significant advantages over existing sensing strategies that rely solely on conventional thermophilic pAgos. First, conventional TtAgo requires high temperatures for efficient cleavage, making it incompatible with standard isothermal detection. With the assistance of dCTP/TthSSB, however, the reaction can proceed at a uniform and moderate temperature, eliminating the need for temperature switching and multiple steps. Second, the ERCB-TtAgo system combines the background suppression functions of both TtAgo and TthSSB with the cleavage activity of TtAgo. This effectively suppresses nonspecific amplification, thereby improving the sensitivity. Furthermore, when programmed by different guide strands, TtAgo cleaves specific probes, enabling multi-target detection. Third, although high concentrations of dNTPs typically exacerbate background signals in conventional isothermal amplification30,31, in our system, they help to further suppress the background. Finally, this method achieves femtomolar-level detection of various miRNAs within a short time, offering high sensitivity and strong specificity, with performance comparable to standard RT-qPCR. Using ERCB-TtAgo, we successfully detect the expression profiles of seven miRNAs in plasma and significantly improve the diagnostic performance for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) by applying a nominal logistic regression model. The analytical and diagnostic performance is confirmed through parallel RT-qPCR experiments. In summary, this study not only expands the applicable temperature range of TtAgo but also establishes an efficient, isothermal and highly sensitive miRNA detection method, thereby providing insights into the enzymatic functionality of Argonaute proteins and their biotechnological applications. Results Moderate-temperature cleavage activity of TtAgo activated by dNTPs/TthSSB TtAgo is traditionally considered to exhibit efficient DNA cleavage activity primarily at high temperatures. While this property is suitable for cleavage applications under elevated temperatures, it significantly limits its integration into conventional molecular diagnostic platforms (Fig. 1a). Our study confirmed the typical cleavage activity of TtAgo under such high-temperature conditions (Fig. 1b). To explore the possibility of modulating TtAgo function through exogenous auxiliary molecules, we screened several potential auxiliary factors: the proteins TthSSB, RepA, UvrB, UvrD, and AddA, as well as the small molecule mixture dNTPs. This selection was based on the UniProt database and the biological context of TtAgo in DNA replication processes11. All six prokaryotic proteins (including TtAgo) were successfully expressed and purified (Supplementary Figs. 1 and 2). Preliminary activity screening indicated that among the various auxiliary molecules, only dNTPs enhanced the cleavage activity of TtAgo at moderate temperatures and mediated the production of specific cleavage products (Fig. 1c). Notably, the AddA protein alone caused nonspecific cleavage, producing fragment clusters, and was therefore excluded from subsequent studies. The combination of dNTPs and TthSSB (dNTPs/TthSSB) synergistically and significantly activated TtAgo, increasing its cleavage efficiency by approximately 9.5-fold compared to dNTPs alone (Fig. 1c and Supplementary Fig. 3a). Subsequent experiments showed that combining dNTPs with any of the other protein auxiliary molecules failed to produce a similar promoting effect (Fig. 1d), further highlighting the uniqueness and high efficiency of the dNTPs/TthSSB combination in activating the moderate-temperature activity of TtAgo.Fig. 1Moderate-temperature cleavage activity of TtAgo activated by dNTPs/TthSSB.a Schematic diagram of TtAgo’s classic cleavage mode under high- and moderate-temperature conditions. b Analysis of the effect of different temperatures on the cleavage activity of conventional TtAgo. Cleavage reactions were performed at a final 200:200:200 nM concentration ratio of TtAgo:gDNA:Target in 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% Triton X-100, pH 8.8. c Gel electrophoresis analysis of TtAgo cleavage activity at 37 °C in the presence of several auxiliary molecules. The NC (negative control) lane contains TtAgo only. Component concentrations: 200 nM TtAgo, 200 nM RepA, 200 nM UvrB, 200 nM UvrD, 200 nM AddA, 200 nM TthSSB, and 1 mM dNTPs. d Gel electrophoresis analysis of TtAgo cleavage activity at 37 °C with different auxiliary proteins and dNTPs. The NC lane contains TtAgo (200 nM) and dNTPs (1 mM) only. Source data are provided as a Source Data file. Moderate-temperature cleavage activity of TtAgo activated by dNTPs/TthSSB. a Schematic diagram of TtAgo’s classic cleavage mode under high- and moderate-temperature conditions. b Analysis of the effect of different temperatures on the cleavage activity of conventional TtAgo. Cleavage reactions were performed at a final 200:200:200 nM concentration ratio of TtAgo:gDNA:Target in 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% Triton X-100, pH 8.8. c Gel electrophoresis analysis of TtAgo cleavage activity at 37 °C in the presence of several auxiliary molecules. The NC (negative control) lane contains TtAgo only. Component concentrations: 200 nM TtAgo, 200 nM RepA, 200 nM UvrB, 200 nM UvrD, 200 nM AddA, 200 nM TthSSB, and 1 mM dNTPs. d Gel electrophoresis analysis of TtAgo cleavage activity at 37 °C with different auxiliary proteins and dNTPs. The NC lane contains TtAgo (200 nM) and dNTPs (1 mM) only. Source data are provided as a Source Data file. Temperature-dependent activation and inhibition of TtAgo by dCTP/TthSSB Since dNTPs are mixtures of small molecules, we systematically evaluated each individual dNTP to identify the specific component responsible for activating TtAgo. As shown in Fig. 2a, in the absence of TthSSB, only dCTP enhanced TtAgo’s DNA cleavage activity, with a more pronounced effect at a higher concentration (4 mM), although the cleavage efficiency remained relatively low (23%, Supplementary Fig. 3b). However, upon the introduction of TthSSB, even a low concentration (1 mM) of dCTP significantly boosted TtAgo activity, indicating a synergistic activation effect between the two components (Fig. 2b). Fluorescence kinetic analysis further confirmed that dCTP is the only component in the dNTPs mixture that assists TtAgo in cleaving fluorescent probes (Supplementary Fig. 3c). As a core activator, the concentration of dCTP significantly influenced TtAgo activity, with only 0.5 mM dCTP substantially increasing cleavage efficiency (Fig. 2c and Supplementary Fig. 3d). Similarly, the protein TthSSB, as another key auxiliary factor, significantly enhanced TtAgo activity even at concentrations as low as 200 nM (Fig. 2d and Supplementary Fig. 3e). Given that Mg2+ mediates substrate cleavage by coordinating catalytic residues (DEDH), we assessed the dependence of Mg2+ concentration and found that TtAgo maintained high cleavage activity between 2 and 8 mM (Supplementary Fig. 3f). In contrast to the conventional TtAgo protocol, which involves pre-loading gDNA at approximately 75 °C to enhance high-temperature cleavage efficiency9,21, we found that in the dCTP/TthSSB-assisted system, mild pre-incubation temperatures between 0 and 50 °C were more conducive to moderate-temperature cleavage activity, whereas higher temperature preincubation severely suppressed efficiency (Fig. 2e). The ratio of gDNA to TtAgo also affected cleavage outcomes, with 1:1 ratio yielding the highest efficiency (Fig. 2f). To determine the guide length preference of TtAgo assisted by dCTP/TthSSB, we tested the cleavage activity of three different sequences of guide DNA (gDNA, gDNA1A, and gDNA1B) within the range of 10 to 22 nt. The results indicated that all sequences exhibited efficient cleavage at 16 nt (Supplementary Fig. 4), consistent with the inherent properties of TtAgo at high temperatures. However, there were differences in the minimum effective lengths among the sequences: gDNA required at least 13 nt (Supplementary Fig. 4a), gDNA1B required 11 nt (Supplementary Fig. 4b, d), and gDNA1A showed activity at 10 nt but had almost no activity between 11 and 14 nt, recovering efficiency at 15 to 22 nt (Supplementary Fig. 4c). This non-monotonic pattern may be attributed to the secondary structures or seed region stability of specific sequences. To make different targets more likely to be efficiently cleaved by dCTP/TthSSB-assisted TtAgo, a guide nucleic acid length of 15–22 nt is recommended, with 16 nt being optimal. To assess the substrate specificity of this system, we used fluorescence kinetics to compare different guide strand and target combinations (gDNA or gRNA with FAM/BHQ1-labeled DNA or RNA targets, Supplementary Table 5). The results showed that the dCTP/TthSSB-assisted TtAgo system could only utilize gDNA guide strands to cleave DNA targets, but not RNA targets (Supplementary Fig. 5). To define the catalytic temperature window of the system, we performed cleavage assays at different temperatures and found strong activity within the 37–60 °C range, whereas the activity of TtAgo was significantly suppressed above 65 °C (Fig. 2g).Fig. 2Synergistic enhancement and suppression of TtAgo activity by dCTP/TthSSB.a Effect of different dNTP types and concentrations on TtAgo cleavage activity without TthSSB. The dNTPs mixture serves as the positive control; NC, negative control without dNTPs. b Effect of individual dNTP on TtAgo cleavage activity with TthSSB present. c Dependence of TtAgo cleavage efficiency on dCTP concentration. d Dependence of TtAgo cleavage activity on TthSSB concentration. e Effect of preincubating the TtAgo/gDNA complex for 3 min at different temperatures on its subsequent cleavage activity. f Effect of the TtAgo to gDNA molar ratio on cleavage activity. g Comparison of cleavage activity between the dCTP/TthSSB-assisted system and TtAgo alone across temperatures. Unless otherwise specified, all experiments were conducted at 37 °C using a TtAgo:gDNA:target molar ratio of 1:1:1 with a reaction time of 1 h. Source data are provided as a Source Data file. Synergistic enhancement and suppression of TtAgo activity by dCTP/TthSSB. a Effect of different dNTP types and concentrations on TtAgo cleavage activity without TthSSB. The dNTPs mixture serves as the positive control; NC, negative control without dNTPs. b Effect of individual dNTP on TtAgo cleavage activity with TthSSB present. c Dependence of TtAgo cleavage efficiency on dCTP concentration. d Dependence of TtAgo cleavage activity on TthSSB concentration. e Effect of preincubating the TtAgo/gDNA complex for 3 min at different temperatures on its subsequent cleavage activity. f Effect of the TtAgo to gDNA molar ratio on cleavage activity. g Comparison of cleavage activity between the dCTP/TthSSB-assisted system and TtAgo alone across temperatures. Unless otherwise specified, all experiments were conducted at 37 °C using a TtAgo:gDNA:target molar ratio of 1:1:1 with a reaction time of 1 h. Source data are provided as a Source Data file. To investigate the universality of the synergistic effect of dCTP and SSB, we tested extreme thermostable single-strand DNA binding protein (ETSSB) and mesophilic SSB from E. coli (E. coli SSB). The results demonstrate that, similar to TthSSB, both ETSSB and E. coli SSB significantly activate the mid-temperature cleavage activity of TtAgo in the presence of dCTP, while the SSB alone is ineffective (Supplementary Fig. 6a). However, there are significant differences in the efficiencies of the different SSBs: at an equal molar concentration of 200 nM, the synergistic efficiency of ETSSB is about 50% that of TthSSB, whereas E. coli SSB requires as much as 10 μM (a 50-fold increase) to achieve a level comparable to that of 200 nM ETSSB (Supplementary Fig. 6b). These results indicate that the synergistic effect of dCTP and SSB is a conserved characteristic of the SSB family, but TthSSB exhibits optimal compatibility at equivalent concentrations due to its co-evolutionary relationship with TtAgo. Efficient catalysis and high-specificity cleavage of dCTP/TthSSB-assisted TtAgo We systematically evaluated the DNA cleavage performance of the dCTP/TthSSB-assisted TtAgo system at two common moderate temperatures: 37 °C and 55 °C. As shown in Fig. 3b and Supplementary Fig. 7a, the reaction at 55 °C achieved complete cleavage of the target substrate within 5–10 min and exhibited significantly higher efficiency than the reaction at 37 °C (Fig. 3a). Subsequent substrate concentration gradient experiments revealed that at 37 °C, target concentrations as low as 20 nM produced detectable cleavage products (Fig. 3c), whereas a higher concentration was required at 55 °C (Fig. 3d, Supplementary Fig. 7b). This indicates a higher substrate affinity at 37 °C. However, when the substrate concentration exceeded 500 nM, the cleavage efficiency at 37 °C declined markedly. In contrast, at 55 °C, TtAgo maintained high cleavage efficiency even at substrate concentrations up to 1000 nM (Supplementary Fig. 7c), demonstrating its superior catalytic efficiency at higher temperature. To quantitatively assess the catalytic performance, we analyzed the system using the Michaelis-Menten kinetic model. The results indicated that the dCTP/TthSSB-assisted TtAgo at 55 °C exhibited higher Km and Kcat values than at 37 °C, and the Kcat/Km ratio increased by 2.4-fold (Fig. 3e and Supplementary Fig. 7d, e). This suggests that while catalytic efficiency is enhanced, substrate affinity is moderately reduced. Compared to conventional TtAgo at 70 °C20, this assisted system exhibited at least a 2.8-fold lower Km and at least a 2.7-fold higher Kcat/Km ratio under moderate-temperature conditions, indicating simultaneously stronger substrate affinity and higher overall catalytic efficiency within the moderate-temperature range.Fig. 3Evaluation of cleavage activity and specificity of dCTP/TthSSB-assisted TtAgo.a, b Time course analysis of target cleavage by TtAgo at 37 °C (a) and 55°C (b). c, d Effect of target concentration on TtAgo cleavage efficiency at 37 °C (c) and 55 °C (d). e Michaelis-Menten kinetic analysis of TtAgo and CbAgo; data points represent the mean ± standard deviation of three independent experiments. f Specificity analysis of TtAgo in recognizing single-base mismatched targets. M0 represents the target with perfect complementarity. g Cleavage efficiency of TtAgo against different targets at 37 °C. NC 1–4 are the negative controls without TtAgo for targets 1–4, respectively. h Schematic diagram illustrating cleavage by different gDNAs designed for specific regions of the KRAS gene. i Cleavage efficiency of TtAgo combined with different gDNAs targeting the sense and antisense strands of KRAS at 55 °C. j, k Fluorescence kinetic curves of TtAgo-mediated cleavage of fluorescently labeled probes of different lengths at 37 °C (j) and 55 °C (k). The solid lines denote the detection results obtained with different reporter probes, whereas the dashed lines represent the corresponding negative controls without TtAgo. Source data are provided as a Source Data file. Evaluation of cleavage activity and specificity of dCTP/TthSSB-assisted TtAgo. a, b Time course analysis of target cleavage by TtAgo at 37 °C (a) and 55°C (b). c, d Effect of target concentration on TtAgo cleavage efficiency at 37 °C (c) and 55 °C (d). e Michaelis-Menten kinetic analysis of TtAgo and CbAgo; data points represent the mean ± standard deviation of three independent experiments. f Specificity analysis of TtAgo in recognizing single-base mismatched targets. M0 represents the target with perfect complementarity. g Cleavage efficiency of TtAgo against different targets at 37 °C. NC 1–4 are the negative controls without TtAgo for targets 1–4, respectively. h Schematic diagram illustrating cleavage by different gDNAs designed for specific regions of the KRAS gene. i Cleavage efficiency of TtAgo combined with different gDNAs targeting the sense and antisense strands of KRAS at 55 °C. j, k Fluorescence kinetic curves of TtAgo-mediated cleavage of fluorescently labeled probes of different lengths at 37 °C (j) and 55 °C (k). The solid lines denote the detection results obtained with different reporter probes, whereas the dashed lines represent the corresponding negative controls without TtAgo. Source data are provided as a Source Data file. Conventional TtAgo is known to exhibit high sensitivity to single-base mutations within positions 9–13 (P9–P13) at the 5’ end of the guide strand9. To evaluate the cleavage specificity of our dCTP/TthSSB system, we systematically investigated the impact of mismatches at various positions along the guide strand at 37 °C. As shown in Fig. 3f and Supplementary Fig. 7f, g, a single-base mutation at the P1 site (Target M1) significantly suppressed cleavage activity, whereas mismatches at sites P2–P16 (Targets M2–M16) almost completely abolished it. These results demonstrate that the system is highly sensitive to mismatches at any position throughout the target sequence and maintains stringent cleavage specificity even at moderate temperatures. We further assessed the system’s cleavage efficiency against different targets. As shown in Fig. 3g and Supplementary Fig. 8a, b, TtAgo cleaved Targets 1–6 with varying efficiencies. To explore its application potential in complex sequence contexts, we designed 12 guide strands targeting sites on both the sense and antisense strands of a 100-nt KRAS gene fragment (Fig. 3h). At 37 °C, TtAgo mediated modest cleavage of the sense strand with a subset of guide strands (gDNA-S1, -S2, -S5, -S6; Supplementary Fig. 8c). Similarly, cleavage of the antisense strand was observed with guides gDNA-AS1, -AS4, -AS5, and -AS6 (Supplementary Fig. 8d). At 55°C, TtAgo achieved efficient cleavage at most target sites, with the exception of those corresponding to gDNA-S3, -S4 and -AS5 (Fig. 3i and Supplementary Fig. 8e). This result confirms the overall improvement in cleavage efficiency at the higher temperature and indicates that, despite some sequence dependency, the system enables efficient cleavage at most target sites. A similar sequence-dependent phenomenon has been reported previously by Greenleaf et al.32. Capitalizing on the ability of pAgos to cleave short oligonucleotide targets and release fluorescent signals, we synthesized reporter probes ranging from 8 to 22 nt (Reporter probes 8–22, Supplementary Table 5). Fluorescence kinetic analysis revealed that the dCTP/TthSSB-assisted TtAgo system generated detectable signals only from probes of at least 16 nt (Fig. 3j, k), indicating a minimum effective target length of 16 nt for this system. To validate the unique properties conferred by the dCTP/TthSSB-assisted system on TtAgo at moderate temperatures, we performed a parallel comparison with the typical mesophilic Argonaute protein CbAgo (Clostridium butyricum Ago). CbAgo exhibits optimal activity around 37 °C, making it suitable for ambient detection, but its cleavage kinetics are generally slow. Previous studies have shown that the Km value of mesophilic CbAgo (2.6 μM) is approximately 1.7-fold higher than that of the conventional thermophilic TtAgo (1.5 μM), while its Kcat/Km value (1.5 × 10⁻4 μM⁻1·min⁻1) is 260-fold lower than that of conventional TtAgo (0.039 μM⁻1·min⁻1)20. In contrast, at the optimal temperature of 55 °C, the dCTP/TthSSB-assisted TtAgo demonstrated higher substrate affinity and catalytic efficiency: its Km was 4.9-fold lower than that of CbAgo, while its Kcat/Km was 1680-fold higher (Fig. 3e). We successfully expressed the CbAgo protein (Supplementary Fig. 9a, b) and further verified the above kinetic differences through cleavage assays. PAGE results indicated that the TtAgo system achieved efficient target cleavage within 5–10 min (Supplementary Fig. 7a), whereas CbAgo showed markedly lower cleavage efficiency within the same period, requiring at least 60 min to reach a comparable cleavage level (Supplementary Fig. 9c). This trend was also confirmed by real-time fluorescence kinetic monitoring: the dCTP/TthSSB-assisted TtAgo reaction reached cleavage equilibrium within 10 min (Fig. 3k), while CbAgo required more than 60 min for the fluorescence signal to plateau (Supplementary Fig. 9d). These results demonstrate that even at the moderate temperature, the dCTP/TthSSB-assisted TtAgo system developed in this study exhibits far superior cleavage speed compared to its mesophilic homolog CbAgo. This not only proves that auxiliary molecular optimization can effectively overcome the reduced activity of thermophilic enzymes at lower temperatures, but also highlights the dual advantages of this approach—maintaining reaction temperature flexibility while significantly shortening detection time. In addition, we tested the effects of dCTP and TthSSB on the activity of CbAgo (Supplementary Fig. 9e) and found that these auxiliary molecular do not enhance its activity, ruling out the possibility that these auxiliary factors affect TtAgo activity through nonspecific mechanisms, such as enhanced DNA stability or changes in ionic strength. To confirm whether the cleavage mechanism of dCTP/TthSSB-assisted TtAgo at moderate temperatures is consistent with that of conventional TtAgo at high temperatures, we performed next-generation sequencing (NGS) to precisely map the cleavage products. Supplementary Fig. 10a shows a schematic of the cleavage assay using a 100-nt KRAS target DNA with gDNA-S5 or gDNA-S6. Denaturing PAGE analysis revealed that conventional TtAgo with gDNA-S5 or gDNA-S6 exhibited low cleavage efficiency at 75 °C (2 h), whereas dCTP/TthSSB-assisted TtAgo achieved efficient cleavage within 1 h (Supplementary Fig. 10b) at 55 °C. NGS analysis showed that when gDNA-S5 was used as the guide, conventional TtAgo generated a weak signal at position 23 of the target (corresponding to the canonical cleavage site opposite the 10th and 11th bases of the gDNA), with a cleavage fraction of only 5.0%, along with a large amount of uncleaved targets (position 1) and a few off-target signals. In contrast, dCTP/TthSSB-assisted TtAgo produced a dominant cleavage signal at position 23, with a cleavage fraction as high as 94.8% (Supplementary Fig. 10c, d). When gDNA-S6 was used as the guide, dCTP/TthSSB-assisted TtAgo similarly generated the dominant signal at the expected position 7 (Supplementary Fig. 10g, h). Coverage plots (Supplementary Fig. 10e, i) and base preference analysis around the cleavage sites (Supplementary Fig. 10f, j) further confirmed that the cleavage patterns under the two conditions were completely identical. These results unequivocally demonstrate that dCTP/TthSSB assisted TtAgo at moderate temperature cleaves the target at exactly the same site as conventional TtAgo at high temperature, and no alternative cleavage patterns induced by the auxiliary factors are observed. Thus, the dCTP/TthSSB system lowers the temperature requirement while fully preserving TtAgo’s canonical cleavage mechanism. In conclusion, our study provides important support for the development of nucleic acid detection tools that combine rapidity, high efficiency, and stability. Allosteric activation and temperature-dependent regulation of TtAgo by dCTP/TthSSB To elucidate the cooperative regulatory mechanism of TtAgo by dCTP/TthSSB and uncover the structural basis for its temperature-dependent functional switch, we first characterized the binding mode of dCTP to TtAgo using molecular docking. Results from Autodock Vina showed that the triphosphate group of dCTP is anchored within the binding pocket via salt bridges (e.g., with ARG 486), while its sugar ring and base moiety form an extensive hydrogen-bond network with key residues in the PIWI domain active pocket (including ALA 479, GLU 512, and ASP 546) (Fig. 4a). To validate the binding of dCTP to TtAgo, we employed surface plasmon resonance (SPR) technology to measure the interactions between TtAgo and four types of dNTPs. The results showed (Fig. 4b and Supplementary Fig. 11a) that dCTP binds to TtAgo, with a dissociation constant (Kd) of 0.851 mM. In contrast, dATP and dGTP exhibited weaker binding affinity to TtAgo than dCTP. Specifically, the affinity of dATP was 2‑fold weaker (Kd = 1.630 mM; Supplementary Fig. 11b, e), and that of dGTP was 2.4‑fold weaker (Kd = 2.041 mM; Supplementary Fig. 11d, e). No quantifiable binding signal was detected for dTTP (Supplementary Fig. 11c, e). These findings clearly indicate that TtAgo can selectively bind to dCTP, which is entirely consistent with our functional experiments where only dCTP was able to synergistically activate TtAgo in conjunction with TthSSB (Fig. 2b). No significant interaction was detected between dCTP and TthSSB (Supplementary Fig. 11f), indicating that dCTP may exerts its primary function by forming a TtAgo-dCTP binary complex. Furthermore, GST pull-down assays verified a direct interaction between TthSSB and TtAgo (Fig. 4c). Together, these results support a model in which, at moderate temperatures, TthSSB binds TtAgo and may participate in a TtAgo-dCTP/TthSSB ternary complex to cooperatively modulate TtAgo activity. Structural modeling of this putative ternary complex revealed a protein-protein interaction interface between TtAgo and TthSSB stabilized by hydrogen bonds (e.g., between HIS 445 and ASN 160) and salt bridges (e.g., between ARG 587 and GLU 224) (Supplementary Fig. 12a). This interface exhibits high charge density and favorable electrostatic complementarity, which may contribute to complex stability and functional regulation at moderate temperatures.Fig. 4Investigation of the synergistic regulatory mechanism of dCTP/TthSSB on TtAgo.a Molecular docking structure of the TtAgo-dCTP complex. The red dashed box indicates the dCTP binding region. TtAgo domains are colored as follows: PIWI domain (yellow), N domain (cyan), PAZ domain (blue), and MID domain (pink). In the close-up view, atoms are colored as follows: oxygen, red; nitrogen, dark blue; dCTP carbon, purple; protein residue carbon, orange. The calculated binding energy between dCTP (PubChem CID: 65091) and TtAgo (PDB ID: 3DLB) is – 7.8 kcal/mol, indicating high affinity. Multiple non-covalent interactions are observed, including hydrogen bonds (red) and salt bridges (yellow). Dashed lines indicate these bonds, with corresponding lengths (in Å) provided. b SPR analysis of the interaction between dCTP and TtAgo. c GST pull-down assay validating the interaction between his-tagged TthSSB and GST-tagged TtAgo. d CD spectroscopy analysis of TtAgo secondary structure at different temperatures. e Far-UV CD spectra of the TtAgo-dCTP complex at different temperatures. f Comparison of theoretical superposition spectra and actual far-UV CD spectra of TtAgo-TthSSB at 35 °C and 65 °C. g Thermal stability analysis of TtAgo, TtAgo-dCTP, TtAgo-TthSSB, and TtAgo-dCTP/TthSSB by DSF. The solid arrows and dashed lines represent the onset unfolding temperatures and physiological temperature, respectively. h, i Fluorescence polarization-based analysis of target substrate binding at 37 °C (h) and 65 °C (i) as a function of protein concentration. Data points represent the mean ± standard deviation of three independent experiments. j Schematic model illustrating the temperature-dependent regulatory mechanism of TtAgo assisted by dCTP/TthSSB. Source data are provided as a Source Data file. Investigation of the synergistic regulatory mechanism of dCTP/TthSSB on TtAgo. a Molecular docking structure of the TtAgo-dCTP complex. The red dashed box indicates the dCTP binding region. TtAgo domains are colored as follows: PIWI domain (yellow), N domain (cyan), PAZ domain (blue), and MID domain (pink). In the close-up view, atoms are colored as follows: oxygen, red; nitrogen, dark blue; dCTP carbon, purple; protein residue carbon, orange. The calculated binding energy between dCTP (PubChem CID: 65091) and TtAgo (PDB ID: 3DLB) is – 7.8 kcal/mol, indicating high affinity. Multiple non-covalent interactions are observed, including hydrogen bonds (red) and salt bridges (yellow). Dashed lines indicate these bonds, with corresponding lengths (in Å) provided. b SPR analysis of the interaction between dCTP and TtAgo. c GST pull-down assay validating the interaction between his-tagged TthSSB and GST-tagged TtAgo. d CD spectroscopy analysis of TtAgo secondary structure at different temperatures. e Far-UV CD spectra of the TtAgo-dCTP complex at different temperatures. f Comparison of theoretical superposition spectra and actual far-UV CD spectra of TtAgo-TthSSB at 35 °C and 65 °C. g Thermal stability analysis of TtAgo, TtAgo-dCTP, TtAgo-TthSSB, and TtAgo-dCTP/TthSSB by DSF. The solid arrows and dashed lines represent the onset unfolding temperatures and physiological temperature, respectively. h, i Fluorescence polarization-based analysis of target substrate binding at 37 °C (h) and 65 °C (i) as a function of protein concentration. Data points represent the mean ± standard deviation of three independent experiments. j Schematic model illustrating the temperature-dependent regulatory mechanism of TtAgo assisted by dCTP/TthSSB. Source data are provided as a Source Data file. To assess conformational changes during activation, we employed far-UV circular dichroism to analyze the effects of dCTP/TthSSB on the secondary structure of TtAgo. TtAgo displayed temperature-sensitive structural properties: below 65 °C, it maintains high α-helical content and a compact fold; as temperature increases, the structure gradually loosens, adopting a dynamic, surface-melted state at the physiological temperature (Fig. 4d and Supplementary Table 2), consistent with previous reports20. The TtAgo-dCTP complex exhibited significantly reduced α-helical content relative to TtAgo alone at both moderate and elevated temperatures (Fig. 4e), indicating that dCTP acts as an allosteric effector promoting partial structural loosening. Above 65 °C, TtAgo-dCTP underwent pronounced secondary structural changes, with α-helical content reduced by up to 37.4% compared to TtAgo at the same temperature (Supplementary Table 2). This excessive loosening likely disorders or destabilizes the catalytic domain, thereby impairing cleavage activity at high temperatures. By contrast, TthSSB itself exhibited high thermal stability, maintaining its native secondary structure even at 85°C (Supplementary Fig. 12b). CD overlay spectra of the TtAgo-TthSSB complex nearly matched the theoretical sum of individual spectra at both 35 °C and 65 °C (Fig. 4f), indicating that TthSSB binding does not substantially alter the overall conformation of TtAgo. We next used differential scanning fluorimetry (DSF) to monitor tertiary structural stability during thermal denaturation. The onset unfolding temperatures of TtAgo, TtAgo-TthSSB, TtAgo-dCTP, and TtAgo-dCTP/TthSSB were all below physiological temperature (Fig. 4g), indicating partial disruption of tertiary structure at physiological temperature and consistent with the conformational flexibility observed by CD. The melting temperature (Tm) of TtAgo-TthSSB did not differ significantly from that of TtAgo alone (Supplementary Fig. 12c, d), confirming that TthSSB does not alter TtAgo stability. Moreover, TtAgo-dCTP and TtAgo-dCTP/TthSSB shared similar Tm values, both markedly lower than that of TtAgo (Supplementary Fig. 12e, f), supporting the conclusion that dCTP binding is the primary driver of tertiary structural destabilization. This dCTP-induced structural flexibility within the TtAgo-dCTP/TthSSB complex may be a prerequisite for modulated catalytic activity at moderate temperatures. We further evaluated substrate binding affinity using fluorescence polarization at 37 °C and 65°C. At 37 °C (Fig. 4h), the Kd of TtAgo-dCTP and TtAgo alone were similar (40.35 ± 3.78 nM vs. 42.17 ± 4.12 nM), whereas the Kd value of TtAgo-TthSSB (26.29 ± 2.46 nM) was 1.6-fold lower than that of TtAgo. The TtAgo-dCTP/TthSSB complex showed the strongest binding (Kd = 23.41 ± 2.28 nM), slightly superior to TtAgo-TthSSB, indicating that dCTP and TthSSB act cooperatively to enhance TtAgo’s substrate binding at moderate temperatures, with TthSSB playing the dominant role. At 65 °C, the Kd values of TtAgo-dCTP and TtAgo remained comparable (50.41 ± 5.23 nM vs. 47.78 ± 4.82 nM), while TtAgo-TthSSB and TtAgo-dCTP/TthSSB displayed slightly elevated Kd values (53.49 ± 5.39 nM and 56.38 ± 5.57 nM, respectively) relative to TtAgo alone (Fig. 4i), suggesting that dCTP confers no binding enhancement and TthSSB may mildly impair substrate association at high temperature. Based on these findings, we propose a temperature-dependent regulatory model (Fig. 4j). At moderate temperatures below 65 °C, dCTP binding partially loosens TtAgo’s conformation, priming the protein for activation, while TthSSB interacts with TtAgo to recruit DNA substrates near the catalytic center. Together, they enhance substrate binding and facilitate efficient cleavage. At elevated temperatures above 65 °C, TtAgo adopts a loosely folded state, and dCTP exacerbates its structural disorder, leading to catalytic domain destabilization. Concurrently, TthSSB no longer improves substrate binding, collectively resulting in severe impairment of TtAgo’s catalytic activity. One-pot ERCB-TtAgo for sensitive miRNA detection Building upon the catalytic activity of dCTP/TthSSB-activated TtAgo at moderate temperatures, we developed a one-pot miRNA detection method called ERCB-TtAgo. As illustrated in Fig. 5a, the mechanism begins with the amplification template (AT), a repetitive sequence fully complementary to the target miRNA at both ends and containing a central Nt.BstNBI nickase recognition site. The target miRNA first hybridizes to the 3’ end of the AT. Subsequently, Bst DNA polymerase extends along the template, synthesizing double-stranded DNA. Once formed, this duplex is recognized and nicked by Nt.BstNBI at its specific site. The Bst DNA polymerase then continues extension from the nick, displacing and releasing miRNA-like single-stranded DNA strands (which serve as gDNA). These displaced gDNA strands act as new targets for subsequent cycles, enabling exponential signal amplification. In the final step, the dCTP/TthSSB-activated TtAgo utilizes the accumulated gDNA as guide strands to cleave fluorescent probes, producing a detectable signal.Fig. 5Comparison of the kinetics and detection sensitivity of traditional EXPAR, two-step TtAgo-based analysis, and the one-pot ERCB-TtAgo method.a Schematic diagram of the ERCB-TtAgo workflow. b Schematic of traditional EXPAR. c Two-step analysis strategy combining EXPAR with TtAgo. d Traditional EXPAR exhibits fast kinetics, generating substantial background signal within 10 min and achieving a detection limit of 1 pM. The reaction system contained: Bst DNA polymerase (0.03 U/μL), Nt.BstNBI (0.2 U/μL), amplification template (25 nM), dNTPs (0.25 mM), and SYBR Green I (0.5 ×). e Two-step analysis based on TtAgo. A 5 μL aliquot of the amplification product obtained after 10 min of EXPAR reaction was mixed with an equal volume of cleavage reaction mixture containing TtAgo (25 nM) and fluorescent probes (25 nM). f Prior to full optimization, the ERCB-TtAgo method achieved a detection sensitivity of 10 fM for miR-21. NC, negative control without targets. Source data are provided as a Source Data file. Comparison of the kinetics and detection sensitivity of traditional EXPAR, two-step TtAgo-based analysis, and the one-pot ERCB-TtAgo method. a Schematic diagram of the ERCB-TtAgo workflow. b Schematic of traditional EXPAR. c Two-step analysis strategy combining EXPAR with TtAgo. d Traditional EXPAR exhibits fast kinetics, generating substantial background signal within 10 min and achieving a detection limit of 1 pM. The reaction system contained: Bst DNA polymerase (0.03 U/μL), Nt.BstNBI (0.2 U/μL), amplification template (25 nM), dNTPs (0.25 mM), and SYBR Green I (0.5 ×). e Two-step analysis based on TtAgo. A 5 μL aliquot of the amplification product obtained after 10 min of EXPAR reaction was mixed with an equal volume of cleavage reaction mixture containing TtAgo (25 nM) and fluorescent probes (25 nM). f Prior to full optimization, the ERCB-TtAgo method achieved a detection sensitivity of 10 fM for miR-21. NC, negative control without targets. Source data are provided as a Source Data file. To evaluate the impact of dCTP/TthSSB-assisted TtAgo on the amplification reaction, we compared the performance of three detection strategies for miR-21, a biomarker for HCC: EXPAR alone, a two-step analysis method combining EXPAR with high-temperature TtAgo, and our one-pot ERCB-TtAgo method. The conventional EXPAR method16,33 uses SYBR Green dye to detect the accumulation of single-stranded gDNA products (Fig. 5b). Although its detection limit for miR-21 is 1 pM, significant nonspecific amplification occurs within 10 min (Fig. 5d). The two-step analysis method involves performing EXPAR at 55 °C, followed by TtAgo-mediated probes cleavage at 85 °C (Fig. 5c). This approach yields a low background signal but suffers from limited sensitivity (detection limit of 10 pM, Fig. 5e), primarily due to the transfer and dilution of reaction products between steps, which also introduces a risk of exogenous contamination. In contrast, our ERCB-TtAgo method effectively overcomes the aforementioned limitations. Even without further optimization, it achieves a detection sensitivity of 10 fM (Fig. 5f) while significantly suppressing the background, offering the dual advantages of high sensitivity and low nonspecific amplification. Optimization and performance characterization of ERCB-TtAgo We systematically optimized several key components of the ERCB-TtAgo detection system. As the core element connecting nucleic acid amplification and signal output, the concentration of TtAgo significantly influenced the detection performance. As shown in Fig. 6a and Supplementary Fig. 13a, 10 nM TtAgo resulted in insufficient activity and slower cleavage of fluorescent probes. Increasing the concentration to 25 nM brought the activity close to saturation, enabling faster detection. A further increase to 50 nM extended the threshold time of the background signal, and detection performance reached its optimum. However, when the concentration was raised further to 150 nM, the reaction was completely inhibited (no signal detected within 1 h), indicating that TtAgo not only cleaves target probes specifically but also strongly suppresses background signals. This effect may be attributed to improved reaction specificity resulting from TtAgo binding to the amplification template (Supplementary Fig. 13b). By using SYBR Green I instead of a reporter probe, we further analyzed the role of TtAgo in the ERCB-TtAgo system. Real-time quantitative data (Supplementary Fig. 13c) showed that upon the addition of TtAgo, the binding of TtAgo to the template resulted in a threshold time delay of approximately 1.3 min for the positive signal, while the threshold time for nonspecific background signals was delayed by about 6.9 min. Meanwhile, the fluorescence intensity during the platform phase remained almost unchanged, indicating that TtAgo has minimal impact on the final amplification yield. Since dCTP is essential for activating the moderate-temperature activity of TtAgo, we further investigated the effect of dNTPs, a mixture that includes dCTP. As the dNTPs concentration increased, the threshold time for the negative control gradually extended (Supplementary Fig. 13d). Notably, high-sensitivity detection of 0.1 fM target was achieved even at 0.5 mM dNTPs (Fig. 6b). However, excessively high dNTPs concentrations also completely inhibited the reaction, indicating that dNTPs may contribute to background suppression. This contrasts sharply with their role in traditional EXPAR systems, where dNTPs serve as chain extension substrates and high concentrations (e.g., 0.5 mM) strongly amplify the background signal (Supplementary Fig. 13e). We speculate that the inhibitory effect of dNTPs may be closely related to TtAgo. To test this, we introduced TtAgo alone into a traditional EXPAR system. The results showed a clear extension in the background threshold time from 20.4 min (0.25 mM dNTPs) to 24.0 min (0.5 mM dNTPs), a marked increase in the signal difference between the target and negative control, and improved detection performance (Supplementary Fig. 13f). We also tested CbAgo alone in the same reaction system (Supplementary Fig. 13g). Notably, even when the concentration of CbAgo was increased to 150 nM, no marked improvement in detection performance was observed. This phenomenon may stem from the higher nucleic acid-binding capacity of TtAgo compared to CbAgo, thereby enabling more effective background suppression in the system. These results further highlight the distinct advantage of TtAgo in this isothermal amplification system. Like other single-stranded DNA-binding proteins34, TthSSB exhibited typical background suppression, with 20 nM sufficient to achieve optimal detection performance (Fig. 6c and Supplementary Fig. 13h). The concentration of Bst DNA polymerase, the key enzyme for amplification cycles, had an optimal window: low-concentration polymerase improved sensitivity for low-concentration miRNA but prolonged reaction time (Fig. 6d). The nicking enzyme Nt.BstNBI required strict concentration control, as both excessively high and low levels impaired performance (Fig. 6e). The concentration of the fluorescent probe for signal output also needed fine-tuning: increasing it from 10 nM to 25 nM improved detection performance, but a further increase to 100 nM raised the background and compromised analytical sensitivity (Fig. 6f). In summary, by systematically optimizing each core component, we have elucidated the unique reaction kinetics of the ERCB-TtAgo method. Notably, TtAgo, activated by dCTP/TthSSB, not only acts as a molecular scissor for probe cleavage but also works synergistically with dCTP/TthSSB to effectively suppress background signals. This integration of multiple functions provides a solid foundation for the high detection performance of ERCB-TtAgo.Fig. 6Performance optimization and evaluation of the ERCB-TtAgo assay.a Optimization of the TtAgo working concentration. NSD means that no amplification signal is detected. b Optimization of the dNTPs concentration. c Optimization of the TthSSB concentration. d Optimization of the Bst DNA polymerase concentration. e Optimization of the Nt.BstNBI concentration. f Optimization of the fluorescent reporter probe concentration. The selected optimal condition in each panel is indicated by a colored background. The lowest detectable concentration showing a statistically significant difference from NC (the negative control without targets) is indicated by an asterisk (*). Statistical analysis used a two-tailed Student’s t test. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. g Representative real-time fluorescence curves of the ERCB-TtAgo assay for detecting serially diluted synthetic miR-21 standards under the optimized conditions. h Standard curve showing the relationship between the threshold time and the logarithm of the miR-21 concentration. The linear detection range is from 0.1 fM to 1000 fM. i Specificity evaluation of the ERCB-TtAgo method. The concentration of each tested miRNA was 10 fM. Error bars represent the mean ± standard deviation of three technical replicates. Source data are provided as a Source Data file. Performance optimization and evaluation of the ERCB-TtAgo assay. a Optimization of the TtAgo working concentration. NSD means that no amplification signal is detected. b Optimization of the dNTPs concentration. c Optimization of the TthSSB concentration. d Optimization of the Bst DNA polymerase concentration. e Optimization of the Nt.BstNBI concentration. f Optimization of the fluorescent reporter probe concentration. The selected optimal condition in each panel is indicated by a colored background. The lowest detectable concentration showing a statistically significant difference from NC (the negative control without targets) is indicated by an asterisk (*). Statistical analysis used a two-tailed Student’s t test. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. g Representative real-time fluorescence curves of the ERCB-TtAgo assay for detecting serially diluted synthetic miR-21 standards under the optimized conditions. h Standard curve showing the relationship between the threshold time and the logarithm of the miR-21 concentration. The linear detection range is from 0.1 fM to 1000 fM. i Specificity evaluation of the ERCB-TtAgo method. The concentration of each tested miRNA was 10 fM. Error bars represent the mean ± standard deviation of three technical replicates. Source data are provided as a Source Data file. Considering potential interference from highly homologous miRNA family members in clinical samples, we selected the full‑length template (AT-21), which is fully complementary to the miRNA target, for the ERCB‑TtAgo system, instead of the truncated template that produces the 16-nt guide (AT-21-16). Using synthetic miR-21, we compared the performance of the two templates. Both exhibited comparable sensitivity for perfectly matched targets across a concentration range of 0.1 fM to 1 pM (Fig. 6g and Supplementary Fig. 14a). However, despite a slightly longer reaction time (30 min vs. 22 min), AT-21 achieved substantially higher specificity in distinguishing single‑base mismatched targets (Supplementary Fig. 14b–e). Specifically, the nonspecific signal of AT-21 for a single‑base mutation at the 7th nucleotide from the 3’ terminus (MP-7) was 18.3%, compared to 87.1% for AT-21-16. Therefore, the full-length template design is the superior choice in clinical diagnostic scenarios requiring high specificity. Based on the optimized system, we further characterized the analytical performance of ERCB-TtAgo. A highly linear relationship (R2 = 0.9993) was observed between the logarithm of the miR-21 concentration and the threshold time, demonstrating excellent quantitative capability (Fig. 6h). For specificity assessment, we expanded the non-target panel to include six HCC-associated miRNAs (miR-26a, miR-27a, miR-122, miR-192, miR-223, and miR-801), one endogenous miRNA (miR-1228), and one terminal-base mismatch of miR-21 (MP-1). Specificity was evaluated by the threshold time difference (∆Tt) between targets and negative controls. All non-target miRNAs produced signals less than 1% of the miR-21 signal, indicating high recognition specificity for ERCB-TtAgo (Fig. 6i). This high specificity likely stems from multiple synergistic mechanisms: highly stringent hybridization between target miRNA and amplification template, precise terminal base recognition by DNA polymerase, background suppression by dCTP/TthSSB and TtAgo, and the inherent specific cleavage activity of TtAgo. In conclusion, the ERCB-TtAgo method established here enables highly sensitive miRNA detection within a relatively short time, offers single-base resolution, and shows significant application potential. Quantitative profiling of miRNAs in early hepatocellular carcinoma diagnosis China accounts for over half of the global annual incidence of HCC, for which mortality ranks second among all malignant tumors35. Early detection and diagnosis are crucial for improving patient survival rates. Studies have shown that combined plasma miRNA analysis based on liquid biopsy holds significant potential for the early detection of HBV-related HCC36,37. Therefore, we selected seven miRNAs closely associated with HCC (miR-21, miR-26a, miR-27a, miR-122, miR-192, miR-223, and miR-801) for investigation. miR-1228 was used as an endogenous reference gene, based on both its documented stability in the literature36,38 and validation within our study (Supplementary Fig. 15). Corresponding amplification templates and detection probes were designed for all targets. We systematically compared the performance of our one-step ERCB-TtAgo method with that of the conventional two-step stem-loop RT-qPCR39 for detecting synthetic miRNA targets. The ERCB-TtAgo method achieved a detection sensitivity of 1 fM for most miRNAs, with the exception of miR-192 (a limit of detection of 10 fM) (Supplementary Figs. 16, 17). This sensitivity was comparable to that of the standard RT-qPCR method (Fig. 7a and Supplementary Fig. 18), despite the latter requiring approximately 2 h to complete. Specifically, RT-qPCR demonstrated sensitivities of 10 fM for miR-1228 and miR-801, 1 fM for miR-223, miR-192, miR-26a, and miR-21, and even 0.1 fM for miR-27a and miR-122. Furthermore, by introducing multiple amplification templates and probes into a single system, we further assessed the multiplex detection capability of the ERCB-TtAgo analysis (Supplementary Fig. 19a). The results indicated no cross-interference among the different miRNAs during detection (Fig. 7b), confirming the high specificity of the assay and its suitability for multiplex detection. Considering the channel limitations of conventional fluorescence PCR instruments, we attempted to divide the eight miRNAs into two tubes for 4-plex detection. Subsequently, we performed multiplex ERCB-TtAgo detection on an equal mixture of the eight synthetic miRNA targets. The results showed that this method could effectively distinguish between 10 fM and 100 fM concentrations of each miRNA target (Fig. 7c), indicating its strong potential for multiplex quantitative analysis.Fig. 7Evaluation of the ERCB-TtAgo method for early diagnosis of hepatocellular carcinoma.a Comparison of sensitivity between ERCB-TtAgo and RT-qPCR in detecting different miRNA targets. b Specificity assessment of individual miRNA detection in the presence of the other seven miRNAs (all at 10 fM). c Response of multiplex ERCB-TtAgo detection to a synthetic mixture of eight miRNAs at concentrations of 10 fM and 100 fM. Each miRNA is reported by a different Taqman probe, as shown in the legend. All reactions were performed in a 20 μL system with the following final concentrations: 25 nM for each amplification template, 0.03 U/μL Bst DNA polymerase, 0.2 U/μL Nt.BstNBI, 50 nM TtAgo, 50 nM TthSSB, 0.5 mM dNTPs, and 10 nM of each reporter probe. d Expression levels of seven HCC-associated miRNAs in the SNU-449 cell line detected by ERCB-TtAgo and RT-qPCR. Error bars show standard deviation (n = 3). e Heatmap of the standardized expression levels of the seven miRNAs across three HCC cell lines (Huh-7, HepG2, and SNU-449). Expression levels were normalized to those in the normal human hepatocyte line LO2. Colors represent the mean values from three technical replicates. f Heatmap of the expression levels of the seven miRNAs in plasma from controls (n = 75, including 29 healthy volunteers, 26 hepatitis B patients, and 20 liver cirrhosis patients). Each sample was analyzed in three technical replicates. A multi-miRNA diagnostic panel was constructed based on a nominal logistic regression model. g Heatmap of the expression levels of the seven miRNAs in plasma from HCC patients (n = 76). h Expression scatter plots for distinguishing HCC (n = 76) from controls (n = 75) using miR-122, miR-223, miR-26a, and miR-27a, miR-192, miR-21, and miR-801 individually. The middle line and error bars represent the mean and standard deviation, respectively. The p-value was calculated using a two-tailed Student’s t test. i Expression scatter plot for distinguishing HCC (n = 76) from controls (n = 75) using the combination of all seven miRNAs. The middle line and error bars represent the mean and standard deviation, respectively. The p-value was calculated using a two-tailed Student’s t test. j ROC curves and AUC analysis for the seven individual miRNA and their combination in the early diagnosis of HCC. k Comparison of the diagnostic performance between ERCB-TtAgo and RT-qPCR for the miRNA panel, based on nominal logistic regression and ROC analysis. All statistical analyses were performed at a 95% confidence interval. Source data are provided as a Source Data file. Evaluation of the ERCB-TtAgo method for early diagnosis of hepatocellular carcinoma. a Comparison of sensitivity between ERCB-TtAgo and RT-qPCR in detecting different miRNA targets. b Specificity assessment of individual miRNA detection in the presence of the other seven miRNAs (all at 10 fM). c Response of multiplex ERCB-TtAgo detection to a synthetic mixture of eight miRNAs at concentrations of 10 fM and 100 fM. Each miRNA is reported by a different Taqman probe, as shown in the legend. All reactions were performed in a 20 μL system with the following final concentrations: 25 nM for each amplification template, 0.03 U/μL Bst DNA polymerase, 0.2 U/μL Nt.BstNBI, 50 nM TtAgo, 50 nM TthSSB, 0.5 mM dNTPs, and 10 nM of each reporter probe. d Expression levels of seven HCC-associated miRNAs in the SNU-449 cell line detected by ERCB-TtAgo and RT-qPCR. Error bars show standard deviation (n = 3). e Heatmap of the standardized expression levels of the seven miRNAs across three HCC cell lines (Huh-7, HepG2, and SNU-449). Expression levels were normalized to those in the normal human hepatocyte line LO2. Colors represent the mean values from three technical replicates. f Heatmap of the expression levels of the seven miRNAs in plasma from controls (n = 75, including 29 healthy volunteers, 26 hepatitis B patients, and 20 liver cirrhosis patients). Each sample was analyzed in three technical replicates. A multi-miRNA diagnostic panel was constructed based on a nominal logistic regression model. g Heatmap of the expression levels of the seven miRNAs in plasma from HCC patients (n = 76). h Expression scatter plots for distinguishing HCC (n = 76) from controls (n = 75) using miR-122, miR-223, miR-26a, and miR-27a, miR-192, miR-21, and miR-801 individually. The middle line and error bars represent the mean and standard deviation, respectively. The p-value was calculated using a two-tailed Student’s t test. i Expression scatter plot for distinguishing HCC (n = 76) from controls (n = 75) using the combination of all seven miRNAs. The middle line and error bars represent the mean and standard deviation, respectively. The p-value was calculated using a two-tailed Student’s t test. j ROC curves and AUC analysis for the seven individual miRNA and their combination in the early diagnosis of HCC. k Comparison of the diagnostic performance between ERCB-TtAgo and RT-qPCR for the miRNA panel, based on nominal logistic regression and ROC analysis. All statistical analyses were performed at a 95% confidence interval. Source data are provided as a Source Data file. To validate the applicability of ERCB-TtAgo in complex samples, we used multiplex ERCB-TtAgo and standard RT-qPCR to quantitatively detect seven miRNAs in the human-derived SNU-449 HCC cell line. The results from both methods were highly consistent (Fig. 7d and Supplementary Fig. 19b, c). Furthermore, using normal human hepatocyte LO2 as a reference, we systematically examined the expression levels of the seven miRNAs in two additional HCC cell lines, Huh-7 and HepG2, via ERCB-TtAgo (Supplementary Fig. 19d, e). The relative miRNA expression profiles across the four cell lines are summarized in Fig. 7e and Supplementary Fig. 19f. The results revealed significant differences in the expression levels of these miRNAs between the three HCC cell lines and the normal hepatocytes, suggesting that these alterations are likely not random but rather driver events closely associated with hepatocarcinogenesis and progression. This finding reinforces the reliability and diagnostic utility of these seven miRNAs as biomarkers for HCC. Finally, we evaluated the potential of ERCB-TtAgo for early HCC diagnosis using plasma samples from 151 subjects (76 HCC patients and 75 controls comprising healthy individuals, hepatitis B patients, and liver cirrhosis patients). Clinical characteristics of the enrolled subjects are provided in Supplementary Table 4. The relative expression levels of individual miRNAs, as determined by ERCB-TtAgo assays, are summarized in the heatmaps shown in Fig. 7f, g. ERCB-TtAgo analysis revealed that compared to the control group, the expression of miR-122, miR-223, miR-26a, and miR-27a was significantly downregulated in HCC patients (fold changes of 0.75, 0.63, 0.60, and 0.65, respectively), while miR-192, miR-21, and miR-801 were significantly upregulated (fold changes of 1.33, 1.47, and 1.96, respectively). The expression differences for all seven miRNAs were statistically significant (Fig. 7h; miR-122, p = 0.013; miR-192, p = 0.001; miR-21, p = 6.91 × 10⁻5; miR-223, p = 0.002; miR-26a, p = 8.4 × 10⁻4; miR-27a, p = 0.004; miR-801, p = 1.91 × 10⁻9). Furthermore, we constructed a combined diagnostic model by performing a weighted linear combination of the expression levels of all seven miRNAs for each subject and used logistic regression to assess the risk of HCC diagnosis (panel; Fig. 7f, g). The results showed that the combined model significantly enhanced the ability to distinguish HCC patients from controls compared to any single miRNA (p = 1.38 × 10–16, Fig. 7i). ROC curve analysis revealed that the area under the curve (AUC) values for individual miRNAs ranged from 0.552 (miR-122) to 0.789 (miR-801), whereas the AUC for the 7-miRNA panel increased to 0.853 (95% CI: 0.791–0.916; Fig. 7j and Supplementary Fig. 20). To validate the detection performance of ERCB-TtAgo, we performed parallel testing on the same RNA samples using RT-qPCR. The AUC for the 7-miRNA combined model by RT-qPCR was 0.856 (95% CI: 0.795–0.918), highly consistent with the ERCB-TtAgo results (Fig. 7k and Supplementary Fig. 21), indicating comparable diagnostic performance to standard RT-qPCR. To assess the differentiation effectiveness of this method in different control populations, we conducted pairwise comparisons between the HCC group and the healthy group, hepatitis B patients, and liver cirrhosis patients. The results showed that this panel has excellent distinguishing capability between HCC and healthy individuals (AUC = 0.945, 95% CI: 0.904–0.986; sensitivity of 82.9%, specificity of 92.6%; Supplementary Fig. 22a). In addition, this panel effectively differentiates HCC from hepatitis B patients (AUC = 0.825, 95% CI: 0.743–0.907; sensitivity of 78.9%, specificity of 76.9%; Supplementary Fig. 22b). For the high-risk population of cirrhosis, this panel also demonstrated good distinguishing ability (AUC = 0.817, 95% CI: 0.703–0.930; sensitivity of 75.0%, specificity as high as 90.0%; Supplementary Fig. 22c), confirming its effectiveness in distinguishing HCC from cirrhosis patients. To further evaluate the diagnostic performance of the ERCB‑TtAgo miRNA panel in comparison with established clinical biomarkers, we analyzed the levels of AFP and PIVKA-II in samples from the same cohort. As shown in Supplementary Fig. 23 and Table 4, the AUC values for AFP and PIVKA-II were 0.790 and 0.824, with sensitivities of 48.7% and 56.6%, and specificities of 89.3% and 90.7%, respectively. In comparison, the ERCB-TtAgo-based miRNA panel achieved an AUC of 0.853, with a sensitivity of 81.6% and a specificity of 81.3% (Supplementary Fig. 20h). This miRNA panel exhibited a higher AUC and a substantially improved sensitivity in early-stage HCC, where conventional serum markers missed more than 40% of cases. These results indicate that the miRNA assay via ERCB-TtAgo can serve as an effective complement to AFP and PIVKA-II, improving the detection rate of early-stage HCC. Furthermore, because miRNAs and AFP/PIVKA-II reflect distinct biological pathways (epigenetic regulation vs. tumor-secreted proteins), their combination may yield synergistic effects. We propose that future prospective studies evaluate the diagnostic performance of a combined model (miRNA panel + AFP + PIVKA-II). In summary, the ERCB-TtAgo method developed in this study demonstrates excellent performance in detection sensitivity, specificity, and multiplex analysis capability. The diagnostic model constructed using the seven plasma miRNA biomarkers shows promising application prospects for early HBV-related HCC screening, providing a powerful tool for liquid biopsy-based cancer diagnosis. Discussion Here, we report the evidence of a synergistic regulatory effect on TtAgo activity by the small molecule dCTP and the protein TthSSB. Conventionally, TtAgo derived from thermophilic bacteria is thought to require temperatures above 65 °C for optimal activity. We demonstrate that the synergistic action of dCTP and TthSSB strongly activates TtAgo at 37–60 °C while suppressing it at higher temperatures. NGS confirms that this synergy does not alter TtAgo’s cleavage site specificity. Mechanistically, far-UV CD spectroscopy and DSF analysis revealed that dCTP binding increases the structural flexibility of TtAgo. We propose that moderate structural flexibility facilitates the enhancement of TtAgo catalytic activity at moderate temperatures, whereas excessive structural looseness is detrimental to its activity at high temperatures. Fluorescence polarization experiments further showed that TthSSB enhances TtAgo’s substrate affinity at moderate temperatures but attenuates it at high temperatures. This effect synergizes with dCTP to reinforce TtAgo’s activity at moderate temperatures while further inhibiting it at elevated temperatures. Michaelis-Menten kinetic analysis confirmed that the dCTP/TthSSB synergy endows TtAgo with higher substrate affinity and catalytic efficiency at moderate temperatures, surpassing its inherent activity at 70 °C. The elucidation of this regulatory mechanism not only expands our understanding of the biological functions of thermophilic pAgos systems but also suggests that such proteins may play broader and more flexible roles in prokaryotes than previously anticipated, extending beyond high-temperature environments. Although our study clearly establishes the regulatory role of dCTP/TthSSB in TtAgo-mediated DNA cleavage, the precise structural basis and detailed biochemical mechanism await further investigation. dCTP binds selectively to TtAgo with moderate affinity (Kd = 0.851 mM), while dTTP shows negligible binding. This selectivity may arise from the unique hydrogen‑bond pattern of dCTP, which needs to be validated by future crystallographic and mutagenesis studies. The apparent paradox that dCTP inhibits TtAgo under high‑temperature in vitro conditions while dCTP and TthSSB coexist in vivo can be explained by concentration differences: at least 0.125 mM dCTP is required to activate TtAgo in vitro (in cooperation with TthSSB), whereas free dCTP concentration in E. coli are reported to be only 0.5–5 μM40. Although the exact dCTP concentration in Thermus thermophilus is unknown, dNTP pools in thermophiles are typically comparable to those in mesophiles. Therefore, the physiological concentration of dCTP is 25–250 times lower than the functional threshold observed in vitro, which is insufficient to exert significant inhibitory or activating effects on TtAgo independently. This explains why bacteria can still grow normally in the presence of dCTP and TthSSB. The high concentrations used in vitro reveal the inherent regulatory capacity of TtAgo, which might only be unleashed in localized microenvironments (e.g., transient dCTP increases near a replication fork) or under specific stress conditions, and always requires TthSSB cooperation. Among pAgo-based methodologies, TtAgo detection platforms are distinguished by their high sensitivity, single-base resolution, and rapid detection, leading to the development of innovative systems such as NAVIGATER combined with LAMP9, Ago-GFETs41 and CAPANA42. These platforms show significant potential for pathogen and tumor diagnostics. However, conventional thermophilic pAgo platforms are often incompatible with isothermal amplification methods, resulting in more complex procedures and longer detection times. Leveraging the activation of TtAgo’s moderate-temperature activity by dCTP/TthSSB, we developed a one-step isothermal amplification system termed ERCB-TtAgo. This system enables highly sensitive and multiplex miRNA detection. It achieves femtomolar-level sensitivity and single-base resolution in miRNA analysis, with performance comparable to RT-qPCR. It also significantly streamlines the workflow and accelerates detection. The system’s high sensitivity, specificity, one-pot contamination-resistant design, and multiplex detection capability collectively underscore its advantages over existing pAgo-based miRNA analysis methods43,44 and position it as a strong competitor to other miRNA detection techniques, such as CRISPR-Cas systems45,46, droplet digital PCR31,47 and nanobiosensors48,49. A pivotal consideration in developing any new enzymatic detection platform is its comparative advantage over existing alternatives. A legitimate question raised is why one should employ an dCTP/TthSSB-assisted TtAgo over a naturally mesophilic counterpart, such as the widely used CbAgo, for moderate-temperature applications. Our direct, side-by-side comparative analysis provides a clear answer: the dCTP/TthSSB-activated TtAgo system is not merely a functional substitute but a decisively superior one. Kinetic studies revealed that at 55 °C, our system exhibited a 4.9-fold lower Km and a 1680-fold higher catalytic efficiency (kcat/Km) than CbAgo at its optimal 37 °C. This translates into dramatically faster operational speeds; activated TtAgo achieves complete target cleavage within 5–10 min, whereas CbAgo requires over 60 min for a comparable outcome. More importantly, within the context of our one-pot isothermal amplification, CbAgo failed to generate a robust signal even at elevated concentrations, while activated TtAgo delivered efficient and specific amplification. This distinction likely stems from TtAgo’s inherently stronger nucleic acid-binding capacity, which, when properly activated at moderate temperatures, provides superior template engagement and background suppression—a critical feature for diagnostic specificity. Therefore, our approach transcends the simple goal of functional compatibility. It leverages a fundamental mechanistic insight to create a system that preserves the programmability and robustness of thermophilic pAgos while outperforming a leading mesophilic Ago in both efficiency and speed, offering a tangible advance for rapid molecular diagnostics. HCC has an insidious onset and a poor prognosis, with a five-year survival rate of only 12.1%50. Early intervention can increase this rate to over 50%51, making early diagnosis crucial for improving patient outcomes. Liquid biopsy technology has attracted significant attention in tumor marker development due to its advantages of speed, minimal invasiveness, and cost-effectiveness52. Among various biomarkers, plasma miRNAs show great potential in HCC diagnosis. In this study, we used HBV-related HCC as a model to evaluate the ERCB-TtAgo platform for detecting miRNAs in clinical plasma samples. Focusing on seven miRNAs closely associated with HCC, we constructed highly sensitive and specific miRNA expression profiles from both cell lines and clinical plasma samples. Although individual plasma miRNA showed only moderate diagnostic performance, logistic regression integration significantly improved the panel’s AUC to 0.853, indicating strong potential for identifying early HCC. Further validation by RT-qPCR confirmed that ERCB-TtAgo is highly consistent with the traditional method in both analytical and diagnostic performance, confirming its reliability and stability. In addition, subgroup analysis using our ERCB-TtAgo platform revealed that the miRNA panel performs excellently in distinguishing HCC from healthy individuals, making it suitable for early screening. Another critical clinical need is the effective differentiation of HCC patients from those with cirrhosis (a precursor state for HCC). Our subgroup analysis indicated that this panel achieves a specificity of 90.0% in distinguishing HCC from cirrhosis, with an AUC of 0.817, confirming its ability to accurately identify malignant transformation. Owing to the insufficient follow-up time of the sample cohort, we are currently unable to provide long-term data for cirrhosis patients. Thus, it remains difficult to determine whether the false positive samples in the cirrhosis group represent early cases that later progressed to HCC. To address this limitation, we will conduct a prospective follow-up study for this cohort. Since all patients in the present cohort had HBV‑related HCC, future studies are required to assess the diagnostic performance of this panel in HCC subgroups of different etiologies and to develop etiology‑specific optimized miRNA panels. In addition, the sample size of this study is relatively limited, and further validation in multi-center, large-scale cohorts is needed. Despite these limitations, this study has sufficiently demonstrated the potential of ERCB-TtAgo as a rapid, sensitive, and specific miRNA detection method for HBV-related HCC diagnosis, serving as both a technical and proof-of-concept validation. It is also important to note that the primary objective of this proof-of-concept clinical study is to evaluate the bioassay rather than the biomarkers. In summary, this study unveils a mechanism of coordinated TtAgo activity regulation by dCTP/TthSSB, expanding the functional understanding of thermophilic pAgos. Leveraging this mechanism, we developed an efficient and reliable one-step miRNA detection platform and validated its clinical application potential. Our strategy highlights the crucial role of host-derived molecules in regulating pAgo function, enabling activation at moderate temperatures, thereby greatly expanding its application prospects. In the future, by expanding sample sizes and biomarker screening, the ERCB-TtAgo system holds promise for playing a significant role in early screening and precise diagnosis of various malignancies. Methods Ethical statement This study complies with all relevant ethical regulations. A total of 151 blood samples meeting the eligibility criteria (Supplementary Table 3) were collected from the Second Affiliated Hospital of Chongqing Medical University between February 2024 and August 2025. The study was approved by the institutional ethics committee of the Second Affiliated Hospital of Chongqing Medical University (approval No. 2024-165). Written informed consent was obtained from all participants. The human plasma samples were analyzed by ERCB-TtAgo and RT-qPCR; no sequencing was performed on human‑derived genetic material. Consequently, this study did not involve the export of human genetic resources, and no approval from the Ministry of Science and Technology of China was required. Materials All reagents, including DNA and RNA oligonucleotides (Supplementary Table 5–7), SYBR Green I dye, acrylamide/bis-acrylamide (29:1), 10 × TBE buffer, 2 × TBE-Urea, GelRed, miRNA First Strand cDNA Synthesis Kit, and the miRNA qPCR Kit (SYBR Green Method), were purchased from Shanghai Sangon. Bst DNA polymerase, Nt.BstNBI, proteinase K, the individual dNTP set (dATP, dCTP, dGTP, and dTTP, 100 mM each), and the dNTPs mix (10 mM) were obtained from New England Biolabs. The miRNeasy Micro Kit and miRNeasy Serum/Plasma Advanced Kit were sourced from Qiagen. Protein expression and purification Codon-optimized versions of the TtAgo, TthSSB, RepA, UvrB, UvrD, and AddA genes were synthesized by Shanghai Sangon and subsequently cloned into the pET28a vector. This generated a series of pET28a-X plasmids for expressing each protein with an N-terminal His tag, as well as a pET28a-TtAgo-GST plasmid for expressing TtAgo with an N-terminal GST tag. Protein expression and purification were carried out as we had shown before. The constructed recombinant plasmids were individually transformed into E. coli BL21(DE3) competent cells. Positive clones were selected on LB agar plates containing 50 μg/mL kanamycin after overnight culture at 37 °C. A single colony was expanded and inoculated into 1 L of LB medium with kanamycin. When the culture reached an OD₆₀₀ of approximately 0.6, protein expression was induced with 0.5 mM IPTG at 18 °C overnight. Cells were then harvested by centrifugation at 5000 × g for 15 min. The cell pellet was resuspended in lysis buffer (8 M urea, 50 mM Tris, 300 mM NaCl, 0.1% Triton X-100, pH 8.0), disrupted by sonication, and centrifuged at 45,000 × g for 90 min at 4 °C to collect the supernatant. Target proteins were purified using Ni-NTA affinity chromatography, eluting with a buffer containing 8 M urea, 50 mM Tris, 300 mM NaCl, 500 mM imidazole, pH 8.0. The purified proteins were dialyzed into appropriate storage buffers (Supplementary Table 1), concentrated with PEG20000, filtered through a 0.45 μm membrane, aliquoted, and stored at –80 °C. Plasmid construction was confirmed by gel electrophoresis (Supplementary Fig. 1), and protein purity and molecular weight were verified by SDS-PAGE (Supplementary Fig. 2). TtAgo/gDNA-mediated cleavage assay Unless otherwise specified, the following standard reaction conditions were employed: Purified TtAgo protein, guide DNA (gDNA), and target DNA were mixed in a 1:1:1 molar ratio (200 nM final concentration each) in Buffer I (containing 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 8 mM MgSO4, 0.1% Triton X-100, pH 8.8). The TtAgo protein was first incubated with gDNA on ice for 3 min to facilitate guide DNA loading. Subsequently, target DNA was added, and the mixture was further incubated at a specified temperature for 1 h to allow the target DNA cleavage reaction to proceed. To investigate the effects of various auxiliary molecules on TtAgo cleavage activity, we added TthSSB, RepA, UvrB, UvrD, AddA, dNTPs, or combinations of these proteins with dNTPs to the preassembled TtAgo/gDNA complex, followed by incubation at 37 °C for 1 h. Furthermore, to identify the specific dNTP components responsible for activating cleavage activity, 1 mM or 4 mM of dATP, dTTP, dCTP, or dGTP were used separately in place of dNTPs. For temperature dependence analysis, samples were incubated at various temperatures using a PCR thermal cycler (Bio-Rad). All reactions were terminated by adding 1 μL of Proteinase K, followed by digestion at 25 °C for 30 min. A 6 μL aliquot of each reaction product was mixed with an equal volume of 2 × TBE-Urea loading buffer. The mixtures were then heated at 95 °C for 3 min and immediately cooled on ice. The DNA fragments were separated by electrophoresis at a constant 180 V for 60 min using a 20% denaturing polyacrylamide gel containing 7 M urea. After staining with GelRed, nucleic acid bands were visualized and analyzed using a BioRad gel imaging system. Library preparation and high throughput sequencing Cleaved samples were analyzed using the Hieff NGS® Methyl-seq ssDNA Library Prep Kit for Illumina® V2 (Yeasen Biotechnology, China) according to the manufacturer’s protocol. Briefly, this workflow comprised three key steps: (i) ligating the 3’ Adapter 2.0 to the 3’ end of the ssDNA, and synthesizing full-length double-stranded DNA (dsDNA) using an extension primer complementary to this adapter; (ii) ligating the truncated 5’ Adapter 2.0 to the 5’ end of the original template strand in the extended dsDNA; (iii) amplifying the product with i5 Primer and i7 Primer, followed by purification using Hieff NGS® DNA Selection Beads (Yeasen Biotechnology) to obtain a large quantity of intact libraries, and finally performing PE150 sequencing on the NovaSeq 6000 system (Illumina, USA). Raw reads were processed through three sequential filtering steps: (i) adapter sequences were removed using Cutadapt (v1.2.1); (ii) low-quality bases were trimmed from the 3’ end toward the 5’ end using Prinseq-lite (v0.19.5); and (iii) chimeric sequences were removed using Usearch (v11.0.667) in de novo mode with default parameters. The remaining high-quality clean reads were retained for further analysis. Coverage analysis for each sample was performed using Unipro UGENE (v53.1). SPR To analyze intermolecular interactions by SPR, the proteins TtAgo and TthSSB were diluted in acetate buffer (pH 5.0) to 10 µg/mL and immobilized on a CM5 chip (Cytiva). The immobilization process consisted of three steps: activation (420 s), coupling (1000 s), and blocking (420 s). The final immobilized levels corresponded to solution concentrations of 33 µg/mL for TtAgo and 68 µg/mL for TthSSB. The analyte dCTP was serially diluted (0.625–2000 µM) for multi-cycle kinetic analysis on a Biacore 8 K system. Each cycle comprised a 120 s association phase and a 120 s dissociation phase, using Buffer I as the running buffer. Data were collected using the Biacore 8 K control software (Cytiva) and processed with Biacore™ Insight Evaluation Software 4.0. The affinity constant was determined by steady-state fitting of five concentration points. CD spectroscopy CD spectroscopy was acquired on a spectropolarimeter (Applied Photophysics) fitted with a 10 mm path length cell to monitor secondary structure changes in TtAgo, TthSSB, TtAgo-dCTP, and TtAgo-TthSSB. All proteins were dissolved in 1 × PBS (pH 8.0) at 1 µM. The TtAgo-dCTP sample was prepared by incubating 1 µM TtAgo with 2.5 mM dCTP at 37 °C for 1 h. The TtAgo-TthSSB sample was prepared by incubating 1 µM TtAgo with 1 µM TthSSB under identical conditions. The CD spectra were recorded over a wavelength range of 190–260 nm. Thermal denaturation was monitored from 35 °C to 90 °C at a heating rate of 1 °C/min, with a 3 min equilibration at each temperature interval before spectral recording. CD spectra at 35 °C, 45 °C, 55 °C, 65 °C, and 75 °C were analyzed for secondary structure content using the DichroWeb server. DSF To analyze protein thermal stability using DSF, the following four samples were prepared in Buffer II (20 mM Tris-HCl, 250 mM NaCl, pH 8.0): TtAgo, TtAgo-TthSSB, TtAgo-dCTP, and TtAgo-dCTP/TthSSB. Specifically, the TtAgo-TthSSB sample was prepared by incubating 2 µM TtAgo with an equimolar concentration of TthSSB in Buffer II for 1 h. The TtAgo-dCTP sample was prepared by incubating 2 µM TtAgo with 5 mM dCTP in the same buffer for 1 h. The TtAgo-dCTP/TthSSB sample was prepared by incubating a mixture of 2 µM TtAgo, 2 µM TthSSB, and 5 mM dCTP in Buffer II for 1 h. Each sample was then transferred to PCR tubes pre-loaded with SYPRO Orange dye (Sigma-Aldrich) at a final 5 × concentration. Using a quantitative real-time PCR (qPCR) instrument (Bio-Rad), the SYPRO Orange dye was excited at 470 nm, and fluorescence emission was monitored at 570 nm to track the protein thermal denaturation process. Fluorescence polarization assay The DNA-binding affinity of TtAgo under different conditions was analyzed by fluorescence polarization using a multi-mode microplate reader (TECAN). Four protein conditions were tested: TtAgo, TtAgo-dCTP (molar ratio 1:2500), TtAgo-TthSSB (1:1), and the ternary complex TtAgo-dCTP/TthSSB (1:2500:1). The DNA target used in all reactions was labeled at the 5’end with a FAM fluorophore (FAM-Target). The experimental procedure was as follows: gDNA and the fluorescently labeled target were first incubated at 95 °C for 3 min in the PCR instrument, followed by gradual cooling to 25 °C at a rate of 0.1 °C/s to form stable gDNA/target complexes. The complex concentration was fixed at 2.5 nM and incubated with a series of concentrations of the four protein samples in Buffer I at 37 °C or 65 °C for 1 h. After incubation, protein-DNA interactions were immediately measured using fluorescence polarization. Cell culture and RNA extraction HCC cell lines SNU-449 (CC0105), Huh-7 (CC0102), and HepG2 (CC0101) were purchased from Cellcook. SNU-449 cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS), Huh-7 in modified DMEM with 10% FBS, and HepG2 in MEM containing 10% FBS. In addition, the human normal hepatocyte line LO2 was obtained from the Cell Bank of the Chinese Academy of Sciences and cultured in DMEM supplemented with 10% FBS. Although LO2 cells were shown to cross‑contaminate with HeLa cells, they were used only for preliminary method validation. Authentication was performed by the vendor upon receipt, and no further re‑authentication was conducted afterward. All cells were maintained in a humidified incubator (Thermo) at 37 °C with 5% CO₂. Total RNA was extracted from the cells using the miRNeasy Micro Kit, strictly following the manufacturer’s instructions. RNA samples were stored at – 80 °C for subsequent use. Plasma preparation and RNA isolation For plasma sample preparation, 3 mL of peripheral blood was collected in EDTA-containing tubes. Within 30 min of collection, the blood was first centrifuged at 1000 × g for 8 min to separate the plasma. The supernatant was then transferred to a new centrifuge tube and subjected to a second centrifugation at 20,000 × g for 10 min at 4 °C to remove residual cellular debris. The resulting supernatant was aliquoted into fresh tubes and stored at – 80 °C. Total RNA from these plasma samples was isolated using the miRNeasy Serum/Plasma Advanced Kit according to the manufacturer’s protocol. Finally, RNA concentration was quantified using a NanoDrop 1000 spectrophotometer (NanoDrop Technologies) and stored at – 80 °C for further analysis. ERCB-TtAgo analysis procedure The ERCB-TtAgo reaction system was prepared as two components, A and B, and stored on ice until use. Component A contained Bst DNA polymerase, Nt.BstNBI nicking enzyme, Buffer I, and DEPC-treated water. Component B included miRNA targets, amplification templates, dNTPs, TtAgo protein, TthSSB protein, reporter probes, Buffer I, and DEPC-treated water. Immediately prior to detection, components A and B were rapidly mixed and transferred to the qPCR instrument. The reaction was carried out in a 20 μL system with the following final concentrations: 25 nM amplification template, 0.03 U/μL Bst DNA polymerase, 0.2 U/μL Nt.BstNBI, 50 nM TtAgo, 50 nM TthSSB, 0.25 mM dNTPs, and 50 nM reporter probe. The reaction was performed at a constant temperature of 55 °C, with real-time fluorescence signals acquired every 30 s. The threshold time (Tt) was determined as the time point at which the fluorescence intensity exceeded an arbitrarily set threshold above the background level. RT-qPCR detection cDNA was synthesized using the miRNAFirst Strand cDNA Synthesis Kit. A 20 μL reverse transcription reaction was assembled in pre-cooled tubes with the following components: 10 μL of 2 × miRNA L-RT Solution mix, 1.5 μL of miRNA L-RT Enzyme mix, 2 μL of miRNA sample, 1 μL of stem-loop primer (SLP, 10 μM), and 5.5 μL of RNase-free water. After gentle mixing and brief centrifugation, the reaction was conducted under the following program: incubation at 16 °C for 30 min, elongation at 37 °C for 30 min, enzyme inactivation at 85 °C for 5 min, and a final hold at 4 °C. The synthesized cDNA was used directly as the template for qPCR. The qPCR was performed in a 20 μL system containing 1 × miRNA qPCR master mix, 0.25 μM specific forward (FP) and universal reverse primers (RP), 2 μL of cDNA template, and RNase-free water to a final volume of 20 μL. The thermal cycling conditions were as follows: initial denaturation at 95 °C for 30 s, followed by 40 cycles of denaturation at 95 °C for 5 s and annealing/extension at 60 °C for 30 s, with fluorescence signals collected at the end of each cycle. Statistics and reproducibility Mean values and standard deviations were calculated using standard functions in Excel. Continuous variables were expressed as mean ± standard deviation, while categorical variables were presented as percentages. Differences between groups were assessed using the two-tailed Student’s t test for continuous variables and the Chi-square test for categorical variables. Specifically, the two-tailed Student’s t test was employed to compare miRNA expression between the HCC group and the control group, with p < 0.05 considered statistically significant. ROC curves were plotted using OriginPro 2017 software (OriginLab Corporation), and AUC was calculated to evaluate diagnostic performance. In addition, a nominal logistic regression model was established using JMP Pro 16 software (JMP Statistical Discovery LLC) to construct a predictive model. For all gel images, each experiment was independently repeated three times with similar results. Representative images from one of the three independent experiments are shown in the figures. We used 76 HCC plasma samples and 75 control plasma samples. We estimated the required sample size for ROC analysis of diagnostic accuracy by comparing the area under a ROC curve (AUC) with a null hypothesis value of 0.5. The sample size was determined based on a significance level of 0.05 and 80% power. A total sample size of 151 is adequate to provide a proof-of-concept assessment of the method’s performance. No data were excluded from the analyses. Human plasma samples were randomly selected from the corresponding disease groups in the affiliated hospital. Blinding was not used because the data were quantitatively measured. Reporting summary Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article. Supplementary information Supplementary Information Reporting Summary Transparent Peer Review file Supplementary Information Reporting Summary Transparent Peer Review file Source data Source Data Source Data